Dogwood Therapeutics (DWTX) Price to Book (2020 - 2026)

Dogwood Therapeutics has reported Price to Book for 7 years, with the latest figure at 0.79 in Q2 2026.

• On a quarterly basis, Price to Book fell 40.5% year-over-year to 0.79 in Q2 2026; TTM through Jun 2026 was 0.79, a 40.5% decrease from a year earlier, with the FY2025 full-year figure at 0.28, up 208.94% from the prior year.
• Price to Book was 0.79 for Q2 2026 at Dogwood Therapeutics, down from 0.87 in the prior quarter.
• The five-year high for Price to Book was 5.39 in Q2 2023, with the low at 0.25 in Q4 2024.
• Average Price to Book over 5 years is 2.15, with a median of 1.45 recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Price to Book jumped 885.57% in 2023, then sank 108.69% in 2024.
• Over 5 years, Price to Book stood at 0.36 in 2022, then jumped by 715.71% to 2.91 in 2023, then sank by 108.69% to 0.25 in 2024, then soared by 208.94% to 0.28 in 2025, then surged by 186.36% to 0.79 in 2026.
• The last three Price to Book figures came in at 0.79 (Q2 2026), 0.87 (Q1 2026), and 0.28 (Q4 2025), per Business Quant data.